The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury

Hepatology

Volumn 54, Issue 3, 2011, Pages 931-939

  Suzuki, Ayako ^a   Brunt, Elizabeth M ^b   Kleiner, David E ^c   Miquel, Rosa ^d   Smyrk, Thomas C ^e   Andrade, Raul J ^f,g   Isabel Lucena, M ^f,g   Castiella, Agustin ^h   Lindor, Keith ^e   Björnsson, Einar ⁱ  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF BARCELONA   (Spain)

^e MAYO CLINIC   (United States)

^f HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

^h HOSPITAL DE MENDARO   (Spain)

ⁱ UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

ACINAR CELL; ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CELL TYPE; CHOLESTASIS; CLINICAL FEATURE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EMPERIPOLESIS; EOSINOPHIL; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; IDIOPATHIC AUTOIMMUNE HEPATITIS; INFLAMMATORY CELL; LIVER BIOPSY; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; PATHOLOGIST; PLASMA CELL; PREDICTION; PRIORITY JOURNAL; ROSETTE FORMATION; SCORING SYSTEM; STANDARD; TOXIC HEPATITIS;

ADULT; AGED; BIOPSY; DRUG-INDUCED LIVER INJURY; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER; MALE; MIDDLE AGED;

EID: 80052023773     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24481     Document Type: Article

References (17)

1. Bjornsson E, Talwalkar J, Treeprasertsuk S, Kamath PS, Takahashi N, Sanderson S, et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. HEPATOLOGY 2010; 51: 2040-2048.
2. Liu ZX, Kaplowitz N. Immune-mediated drug-induced liver disease. Clin Liver Dis 2002; 6: 755-774.
3. Uetrecht J. Immunoallergic drug-induced liver injury in humans. Semin Liver Dis 2009; 29: 383-392.
4. Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf 2007; 30: 277-294.
5. Kirk AP, Jain S, Pocock S, Thomas HC, Sherlock S. Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis. Gut 1980; 21: 78-83.
6. Milkiewicz P, Hubscher SG, Skiba G, Hathaway M, Elias E. Recurrence of autoimmune hepatitis after liver transplantation. Transplantation 1999; 68: 253-256.
7. Soloway RD, Summerskill WH, Baggenstoss AH, Geall MG, Gitnick GL, Elveback IR, Schoenfield LJ. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 1972; 63: 820-833.
8. Kleiner DE. The pathology of drug-induced liver injury. Semin Liver Dis 2009; 29: 364-372.
9. Czaja AJ. Autoimmune hepatitis. In: McSween R, ed. Pathology of the Liver. New York, NY: Churchill Livingstone; 2007.
10. Dienes HP, Erberich H, Dries V, Schirmacher P, Lohse A. Autoimmune hepatitis and overlap syndromes. Clin Liver Dis 2002; 6: 349-362, vi.
11. Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. HEPATOLOGY 2008; 48: 169-176.
12. Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 1990; 11: 272-276.
13. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938.
14. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699.
15. Heurgué A, Bernard-Chabert B, Diebold M, Vitry F, Louvet H, Geoffroy P. Drug-induced autoimmune hepatitis: a frequent disorder. Gut 2007; 56(Suppl III): A271.
16. Hammerich L, Heymann F, Tacke F. Role of IL-17 and Th17 cells in liver diseases. Clin Dev Immunol 2011; 2011: 345803.
17. Oo YH, Adams DH. The role of chemokines in the recruitment of lymphocytes to the liver. J Autoimmun 2010; 34: 45-54.